Which cisplatin timing works best with radiation for head and neck cancer?
NCT ID NCT02994069
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 25 times
Summary
This study compares two ways of giving the chemotherapy drug cisplatin alongside standard radiation for people with advanced head and neck cancer. One group gets cisplatin every three weeks, the other weekly. The goal is to see which schedule causes fewer severe side effects and to measure how oxidative stress relates to toxicity. About 80 adults with squamous cell carcinoma of the head and neck are enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Kentucky
Lexington, Kentucky, 40536, United States
Conditions
Explore the condition pages connected to this study.